These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31019484)

  • 21. White matter abnormalities in gene-positive myoclonus-dystonia.
    van der Meer JN; Beukers RJ; van der Salm SM; Caan MW; Tijssen MA; Nederveen AJ
    Mov Disord; 2012 Nov; 27(13):1666-72. PubMed ID: 23114862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Costs of treating dystonias and hemifacial spasm with botulinum toxin A.
    Dodel RC; Kirchner A; Koehne-Volland R; Künig G; Ceballos-Baumann A; Naumann M; Brashear A; Richter HP; Szucs TD; Oertel WH
    Pharmacoeconomics; 1997 Dec; 12(6):695-706. PubMed ID: 10175981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A change in brain white matter after shunt surgery in idiopathic normal pressure hydrocephalus: a tract-based spatial statistics study.
    Kanno S; Saito M; Kashinoura T; Nishio Y; Iizuka O; Kikuchi H; Takagi M; Iwasaki M; Takahashi S; Mori E
    Fluids Barriers CNS; 2017 Jan; 14(1):1. PubMed ID: 28132644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between symptom dimensions and white matter alterations in obsessive-compulsive disorder.
    Yagi M; Hirano Y; Nakazato M; Nemoto K; Ishikawa K; Sutoh C; Miyata H; Matsumoto J; Matsumoto K; Masuda Y; Obata T; Iyo M; Shimizu E; Nakagawa A
    Acta Neuropsychiatr; 2017 Jun; 29(3):153-163. PubMed ID: 27620171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia.
    Naumann M; Yakovleff A; Durif F;
    J Neurol; 2002 Jan; 249(1):57-63. PubMed ID: 11954869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The plasticity of the corticospinal tract in children with obstetric brachial plexus palsy after Botulinum Toxin A treatment.
    Xi SD; Zhu YL; Chen C; Liu HQ; Wang WW; Li F
    J Neurol Sci; 2018 Nov; 394():19-25. PubMed ID: 30196131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. White Matter Microstructure in Idiopathic Craniocervical Dystonia.
    Pinheiro GL; Guimarães RP; Piovesana LG; Campos BM; Campos LS; Azevedo PC; Torres FR; Amato-Filho AC; França MC; Lopes-Cendes I; Cendes F; D'Abreu A
    Tremor Other Hyperkinet Mov (N Y); 2015; 5():. PubMed ID: 26056610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The timing of stereotactic radiosurgery for medically refractory trigeminal neuralgia: the evidence from diffusion tractography images.
    Lee CC; Chong ST; Chen CJ; Hung SC; Yang HC; Lin CJ; Wu CC; Chung WY; Guo WY; Pan DH; Wu HM; Sheehan JP; Lin CP
    Acta Neurochir (Wien); 2018 May; 160(5):977-986. PubMed ID: 29397449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Botulinum A toxin in the treatment of focal dystonias].
    Domzał TM
    Neurol Neurochir Pol; 1998; 32 Suppl 1():35-44. PubMed ID: 9608551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No microstructural white matter alterations in chronic and episodic migraineurs: a case-control diffusion tensor magnetic resonance imaging study.
    Neeb L; Bastian K; Villringer K; Gits HC; Israel H; Reuter U; Fiebach JB
    Headache; 2015 Feb; 55(2):241-51. PubMed ID: 25644380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dystonia in Machado-Joseph disease: Clinical profile, therapy and anatomical basis.
    Nunes MB; Martinez AR; Rezende TJ; Friedman JH; Lopes-Cendes I; D'Abreu A; França MC
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1441-7. PubMed ID: 26552869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study.
    Nevrlý M; Hluštík P; Hok P; Otruba P; Tüdös Z; Kaňovský P
    Exp Brain Res; 2018 Oct; 236(10):2627-2637. PubMed ID: 29971454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
    Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
    Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion tensor imaging and ventricle volume quantification in patients with chronic shunt-treated hydrocephalus: a matched case-control study.
    Tan K; Meiri A; Mowrey WB; Abbott R; Goodrich JT; Sandler AL; Suri AK; Lipton ML; Wagshul ME
    J Neurosurg; 2018 Dec; 129(6):1611-1622. PubMed ID: 29350598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification and Monitoring of the Effect of Botulinum Toxin A on Paretic Calf Muscles of Children With Cerebral Palsy With MRI: A Preliminary Study.
    Weidensteiner C; Madoerin P; Deligianni X; Haas T; Bieri O; Akinci D'Antonoli T; Bracht-Schweizer K; Romkes J; De Pieri E; Santini F; Rutz E; Brunner R; Garcia M
    Front Neurol; 2021; 12():630435. PubMed ID: 33935939
    [No Abstract]   [Full Text] [Related]  

  • 37. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of botulinum toxin type A in the treatment of cervical dystonia.
    Comella CL; Jankovic J; Brin MF
    Neurology; 2000; 55(12 Suppl 5):S15-21. PubMed ID: 11188979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.
    Duarte GS; Castelão M; Rodrigues FB; Marques RE; Ferreira J; Sampaio C; Moore AP; Costa J
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD004314. PubMed ID: 27782297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
    Sankhla C; Jankovic J; Duane D
    Mov Disord; 1998 Jan; 13(1):150-4. PubMed ID: 9452341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.